TurboID is an engineered promiscuous biotin ligase created by directed evolution of Escherichia coli BirA. The wild-type BirA enzyme biotinylates a single specific substrate peptide with high selectivity; a single-point mutation (R118G or R118S) relaxes this selectivity to give the enzyme its promiscuous character—the basis of the original BioID tool, introduced in 2012 (Roux et al., 2012).
TurboID was created in Alice Ting’s laboratory at Stanford using yeast surface display-based directed evolution. Over 10 million enzyme variants were screened for biotinylation efficiency under short biotin incubation windows. The winning clone—TurboID—carries 15 mutations in its catalytic domain relative to the BirA R118S template. A smaller companion, miniTurbo (~27 kDa), was derived from the same process with an N-terminal domain deletion and 12 total mutations (Branon et al., 2018).
The result: TurboID achieves equivalent biotinylation in 10 minutes where BioID requires 18 hours. This 100-fold acceleration changes the types of experiments researchers can design. With BioID, pulse-chase studies capturing stimulus-triggered protein assembly were impractical. TurboID makes them routine.
TurboID belongs to the broader family of proximity labeling (PL) techniques, which also includes peroxidase-based approaches such as APEX2. For a direct comparison of TurboID against APEX2 and AP-MS across throughput, toxicity, and spatial precision, refer to our guide on choosing the right protein interaction mapping strategy.
At the core of TurboID proximity labeling is a two-step enzymatic reaction: activation of biotin, followed by transfer of the activated species to neighboring proteins.
TurboID catalytic mechanism: ATP-dependent bioAMP generation, promiscuous release, and covalent biotinylation of proximal lysine residues within ~10 nm.
The effective labeling radius is approximately 10 nm, governed by the aqueous half-life of bioAMP (seconds at physiological pH). Because biotinylation is covalent and stable under SDS-denaturing conditions, all proximity relationships are locked in at the moment of the pulse. Cell lysis conditions do not need to preserve protein–protein interactions, eliminating a major source of variability that affects co-immunoprecipitation and pull-down methods.
A well-controlled TurboID experiment moves through five stages. Each stage involves design decisions that directly affect data quality. For a complete technical deep-dive from construct validation to LC-MS/MS parameter selection, refer to our detailed TurboID workflow guide.
TurboID workflow overview: five stages from construct design through quantitative LC-MS/MS proteomics.
Stage 1: Fusion Construct Design. TurboID is fused in-frame to the bait protein. Key decisions: tag position (N- or C-terminal, based on bait topology), linker length (5–15 residue Gly-Ser linkers allow rotational freedom and maximize the labeling sphere), enzyme variant (full TurboID 35 kDa vs. miniTurbo 27 kDa), and parallel design of a negative control construct. For guidance on designing controls that minimize false positives, see our article on TurboID control design.
Stage 2: Expression System and Cell Model. Common delivery options are transient transfection (fastest), stable lentiviral integration (reproducible), or CRISPR knock-in at the endogenous locus (preferred to avoid overexpression artifacts). TurboID’s activity at 25°C makes it suitable for all major invertebrate and plant model systems where BioID’s 37°C requirement is restrictive.
Stage 3: Biotin Pulse and Quench. Cells receive exogenous biotin (typically 50–500 µM) for a defined window—10 minutes in mammalian cell culture. Pulse length is adjusted upward for whole-organism experiments where biotin delivery kinetics, not enzyme activity, are rate-limiting. A no-biotin control undergoes identical processing with biotin-free medium.
Stage 4: Lysis and Streptavidin Enrichment. Cells are lysed under denaturing conditions (RIPA + SDS or urea-based buffers), disrupting all non-covalent complexes. The lysate is incubated with streptavidin magnetic beads, washed with progressively stringent buffers (including SDS and urea washes), and biotinylated proteins are eluted by boiling in SDS loading buffer with excess biotin or desthiobiotin.
Stage 5: LC-MS/MS Identification and Quantification. Eluted proteins are trypsin-digested and analyzed by LC-MS/MS. Quantitative methods—LFQ, TMT multiplexing, or SILAC—compare bait to control. Proteins enriched at ≥2-3 fold with FDR-corrected p < 0.05 constitute the candidate proximal proteome. For a complete guide to interpreting the resulting protein lists, see our resource on TurboID mass spectrometry data analysis.
| Feature | TurboID | BioID | APEX2 | AP-MS / Co-IP |
| Labeling time | ~10 min | 18–24 h | 1–2 min | N/A |
| Requires H₂O₂ or toxic reagents | No | No | Yes | No |
| Captures transient interactions | Yes | Yes | Yes | Limited |
| Works in living cells | Yes | Yes | Yes | Variable |
| Spatial resolution | ~10 nm | ~10 nm | ~10 nm | Not defined |
| Temporal resolution | Yes | No | Yes | No |
| Viable in whole organisms | Yes | Yes | Limited | Limited |
| Temperature requirement | 25–37°C | 37°C | 37°C | N/A |
Speed enables temporal biology. A 10-minute labeling window allows capture of protein neighborhoods at defined moments: before and after receptor activation, at specific cell cycle phases, or at timepoints during differentiation. This temporal resolution was not accessible with BioID.
Covalent labeling survives denaturing lysis. Biotinylation is stable through SDS-PAGE conditions, enabling stringent washes that substantially reduce background compared to affinity purification methods that require intact interaction partners.
No toxic reagents. Unlike APEX2, TurboID requires only biotin—a vitamin found in standard culture media—making it safe for primary cells, neurons, and whole organisms without acute toxicity.
Compartment addressability. Targeting sequences direct TurboID to the mitochondrial matrix, ER lumen, nucleus, cytoplasm, plasma membrane inner leaflet, or any compartment with a defined targeting code, generating spatially precise proteome snapshots.
Split-TurboID divides the enzyme into two inactive fragments (N-TurboID and C-TurboID). Individually, each fragment has no enzymatic activity. When brought into proximity by a protein–protein interaction, a chemical inducer of dimerization, or membrane–membrane apposition, the fragments reconstitute an active enzyme that biotinylates its local environment (Cho et al., 2020).
This architecture enables two new experimental modes:
Split-TurboID adds design complexity and is typically reserved for experiments where the contact site or interaction-dependent specificity cannot be achieved by compartment-targeting the full-length enzyme.
TurboID application landscape across subcellular compartments, model organisms, and research disciplines.
Nuclear and chromatin biology. TurboID fused to nuclear pore complex components has mapped the nuclear envelope proteome with high resolution, identifying dozens of pore-proximal proteins undetectable by biochemical fractionation. Chromatin-bound transcription factors, polycomb group proteins, and heterochromatin components are now routinely profiled with TurboID.
Organelle proteomics. The original Branon et al. (2018) validation mapped the mitochondrial matrix, ER lumen, and nucleus in human cells, and multiple tissues in Drosophila and C. elegans—establishing that TurboID defines organelle-specific proteomes more comprehensively than conventional fractionation, capturing low-abundance and dual-localization proteins.
Synaptic and neuroproteomics. The postsynaptic density (PSD) resists standard biochemical isolation. TurboID fused to PSD-95 has enabled in situ proteome mapping in primary neurons and mouse brain tissue. Cell-type-specific TurboID expression under CaMKIIα or Aldh1l1 promoters has generated distinct proteomic profiles of neuronal and astrocyte populations in intact mouse brain (Go et al., 2021).
Phase-separated biomolecular condensates. Stress granules, P-bodies, paraspeckles, and transcriptional condensates are disrupted by standard purification. TurboID fused to condensate markers (e.g., G3BP1 for stress granules) enables in situ biotinylation of the condensate proteome in intact cells under conditions that maintain condensate integrity.
Signaling pathway reconstruction. Fusing TurboID to a kinase or receptor and triggering activation during a defined biotin pulse captures stimulus-dependent protein neighborhood changes, enabling temporal dissection of signaling complex assembly and disassembly at receptor tyrosine kinases, GPCRs, and kinase scaffolds.
Plant biology. TurboID is validated in Arabidopsis, rice, and other plant species where BioID fails (37°C requirement) and APEX2 is complicated by high endogenous peroxidase activity. TurboID has mapped brassinosteroid signaling networks, plasmodesmata-associated proteomes, and cell wall remodeling complexes.
In vivo organism-level proteomics. CRISPR-mediated TurboID knock-in at endogenous loci has been achieved in C. elegans, Drosophila, zebrafish, and mouse, enabling proximity labeling at endogenous expression levels in specific tissues and developmental stages. DIA-based mass spectrometry now enables quantitative interactome profiling from in vivo TurboID experiments with improved sensitivity and reproducibility (Go et al., 2025).
The key decision points when selecting between proximity labeling variants:
For a comprehensive side-by-side comparison including BioID2 and miniTurbo across all decision criteria, see our dedicated resource on TurboID vs. BioID vs. miniTurbo.
Understanding TurboID’s limitations is essential before committing to experimental design:
For a systematic guide to diagnosing and resolving these issues, refer to our TurboID troubleshooting guide. For strategies to distinguish true interactors from background in your dataset, see our resource on how to distinguish true interactors from background in TurboID experiments.
The minimum control set for any TurboID experiment includes four elements:
For detailed guidance on each control type and how to apply them in statistical filtering, see our article on TurboID control design. For guidance on designing TurboID experiments from scratch, including construct strategy, expression system selection, and replication plan, see our resource on how to design a TurboID experiment for PPI studies.
Creative Proteomics offers an end-to-end TurboID proximity labeling service covering construct design consultation, expression system selection, proximity labeling with validated controls, streptavidin enrichment, LC-MS/MS acquisition, and quantitative data analysis.
Our team can advise on construct design, control strategy, appropriate cell models, and downstream bioinformatics—including GO enrichment, pathway mapping, and network visualization. If you are evaluating method options, we can help compare TurboID against AP-MS, BioID, or pull-down approaches.
Ready to start? Submit an inquiry through our online inquiry page and a scientist will discuss your project goals and sample requirements.
What is TurboID proximity labeling and how does it work?
TurboID proximity labeling is a method in which an engineered biotin ligase (TurboID) is fused to a protein of interest and expressed in living cells. When supplied with exogenous biotin, TurboID generates reactive biotin-AMP intermediates that covalently label lysine residues on all proteins within approximately 10 nm. Biotinylated proteins are captured with streptavidin beads and identified by mass spectrometry.
What is the labeling radius of TurboID?
The effective labeling radius of TurboID is approximately 10 nm, governed by the aqueous half-life of the reactive bioAMP intermediate—roughly the diameter of a large globular protein, sufficient to capture direct partners, transient interactors, and structural neighbors within the same complex or organelle microenvironment.
How long does a TurboID biotin pulse need to be?
In mammalian cell culture, a 10-minute biotin pulse (50–500 µM) is sufficient for robust labeling. Pulse length can be extended for dynamic or in vivo experiments, but longer pulses reduce temporal resolution and may increase background. BioID requires 18–24 hours to achieve comparable biotinylation.
What organisms and cell systems are compatible with TurboID?
TurboID has been validated in HEK293, HeLa, and other mammalian cell lines; S. cerevisiae; C. elegans; D. melanogaster; zebrafish; mouse; and multiple plant species. Its activity at 25°C makes it suitable for all major invertebrate and plant model systems.
Can TurboID distinguish direct binding partners from proximity neighbors?
No—biotinylation reflects spatial proximity (~10 nm), not direct binding. A detected protein may be a direct interactor, a compartment co-resident, or a structural neighbor with no functional relationship to the bait. Orthogonal validation experiments (Co-IP, co-fractionation) are needed to confirm direct interactions among candidates.
Does TurboID require crosslinking or fixation?
No. Biotinylation is covalent and captured during the labeling step in living cells. Cells can be lysed under fully denaturing conditions after the biotin pulse without loss of proximity information.
What controls are required for a reliable TurboID experiment?
Essential controls include: a no-biotin control; a localization or expression-matched control; and three or more independent biological replicates. For detailed guidance, see our TurboID control design resource.
What outputs does a TurboID LC-MS/MS experiment produce?
A standard experiment delivers a quantified protein list with fold-enrichment and statistical significance values, a filtered candidate proximal proteome, and optional downstream analysis including GO enrichment, KEGG pathway mapping, and protein interaction network visualization using tools such as STRING.
References
Related Services
For Research Use Only. Not for use in diagnostic procedures.
Author: CAIMEI LI | Senior Scientist at Creative Proteomics
Online Inquiry